Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Brennum, L.T."'
Publikováno v:
Larsen, A K, Brennum, L T, Jensen, J E, Sanchez, C, Halldin, C & Andersen, P H 2004, ' Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects ', Br. J. Pharmacol., vol. 141, pp. 1015-1023 .
1. Binding of the novel radioligand (3)H-2-(2-dimethylaminomethyl-phenylsulphanyl)-5-methyl-phenylamine ((3)H-MADAM) to the serotonin transporter (SERT) was used to characterise a range of selective serotonin re-uptake inhibitors (SSRIs) in vitro and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fd05bdd3781cc1d29fe6304416659581
https://europepmc.org/articles/PMC1574267/
https://europepmc.org/articles/PMC1574267/
Publikováno v:
Sanchez, C, Bergqvist, P B, Brennum, L T, Gupta, S, Hogg, S, Larsen, A & Wiborg, O 2003, ' Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities ', Psychopharmacology (Berl), vol. 167, no. 4, pp. 353-362 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::c694ee6ca226ff8c2f2442541ff007c8
https://pure.au.dk/portal/da/publications/escitalopram-the-senantiomer-of-citalopram-is-a-selective-serotonin-reuptake-inhibitor-with-potent-effects-in-animal-models-predictive-of-antidepressant-and-anxiolytic-activities(ec1029f0-6b45-11dc-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/escitalopram-the-senantiomer-of-citalopram-is-a-selective-serotonin-reuptake-inhibitor-with-potent-effects-in-animal-models-predictive-of-antidepressant-and-anxiolytic-activities(ec1029f0-6b45-11dc-bee9-02004c4f4f50).html
Autor:
Sóskuti, Emőke1,2 (AUTHOR) emoke.soskuti@crl.com, Szilvásy, Nóra1 (AUTHOR) nora.szilvasy@crl.com, Temesszentandrási-Ambrus, Csilla1 (AUTHOR) csilla.temesszentandrasi-ambrus@crl.com, Urbán, Zoltán1 (AUTHOR) zoltan.urban@crl.com, Csíkvári, Olivér1 (AUTHOR) oliver.csikvari@crl.com, Szabó, Zoltán3 (AUTHOR) szabo.zoltan@med.u-szeged.hu, Kecskeméti, Gábor3 (AUTHOR) kecskemeti.gabor@med.u-szeged.hu, Pusztai, Éva4 (AUTHOR) pusztai.eva@vbk.bme.hu, Gáborik, Zsuzsanna1 (AUTHOR) zsuzsanna.gaborik@crl.com
Publikováno v:
Pharmaceutics. Jun2024, Vol. 16 Issue 6, p736. 21p.
Autor:
Mørk, A., Brennum, L.T., Fallón, S., Bisulco, S., Frederiksen, K., Bang-Andersen, B., Lassen, A.B., Zhong, H., Sanchez, C., Stensbøl, T.B.
Publikováno v:
In European Neuropsychopharmacology 2009 19 Supplement 3:S439-S439
Publikováno v:
In Schizophrenia Research 2008 102(1) Supplement 2:60-60
Publikováno v:
In European Neuropsychopharmacology 2007 17 Supplement 4:S478-S478
Autor:
Landau, Anne Marlene1,2 (AUTHOR) alandau@clin.au.dk, Jakobsen, Steen2 (AUTHOR), Thomsen, Majken Borup1,2 (AUTHOR), Alstrup, Aage Kristian Olsen2 (AUTHOR), Orlowski, Dariusz3 (AUTHOR), Jacobsen, Jan2 (AUTHOR), Wegener, Gregers1 (AUTHOR), Mørk, Arne4 (AUTHOR), Sørensen, Jens Christian Hedemann3 (AUTHOR), Doudet, Doris J.5 (AUTHOR) ddoudet@mail.ubc.ca
Publikováno v:
Biomolecules (2218-273X). Apr2023, Vol. 13 Issue 4, p674. 16p.
Autor:
Fan, Hueng-Chuen1,2,3 (AUTHOR), Chiang, Kuo-Liang4,5 (AUTHOR), Chang, Kuang-Hsi6 (AUTHOR), Chen, Chuan-Mu3,7 (AUTHOR) chchen1@dragon.nchu.edu.tw, Tsai, Jeng-Dau8,9 (AUTHOR) chchen1@dragon.nchu.edu.tw
Publikováno v:
International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 6, p5270. 30p.
Publikováno v:
In European Neuropsychopharmacology 2004 14 Supplement 3:S385-S385
Autor:
Gebauer, Lukas1 (AUTHOR) lukas.gebauer@med.uni-goettingen.de, Rafehi, Muhammad1 (AUTHOR), Brockmöller, Jürgen1 (AUTHOR)
Publikováno v:
Biomolecules (2218-273X). Oct2022, Vol. 12 Issue 10, pN.PAG-N.PAG. 14p.